Earnings History Data for TransCode Therapeutics (RNAZ) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
TransCode Therapeutics
TransCode Therapeutics is an emerging RNA oncology company. Its platform of investigational drug candidates is dedicated to improving patient outcomes encompassing a variety of tumor types. The company's lead therapeutic candidate includes TTX-MC138. TransCode Therapeutics is based in BOSTON.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | AH | RNAZ | TransCode Therapeutics | 7.00 | -0.16 | -0.49 | 0.00 | 0.3349 | -0.02 (-4.29%) |
0.37 | 0.02 (6.32%) |
0.22 - 18.66 | 241,526 | 460,000 | 10,359 | |||
|
|
||||||||||||||||||
| 14-08-2024 | AH | RNAZ | TransCode Therapeutics | 2.00 | -0.74 | -0.58 | 0.00 | 0.24 | 0.01 (5.31%) |
0.23 | 0.0 (1.23%) |
0.22 - 128.00 | 393,815 | 600,000 | 77,372 | |||
|
|
||||||||||||||||||
| 14-08-2023 | AH | RNAZ | TransCode Therapeutics | 1.00 | -3.29 | -3.39 | 0.00 | TransCode Therapeutics reports Q2 results [8/15/2023 10:39 AM] |
1.62 | -0.03 (-1.82%) |
1.80 | 0.15 (9.09%) |
1.46 - 31.00 | 18,009 | 50,000 | 1,572 | ||
| 14-11-2022 | PM | 4:15 PM ET (Nov 14) |
RNAZ | TransCode Therapeutics | 7.00 | -0.33 | -0.40 | 0.00 | TransCode Therapeutics reports Q3 results [11/15/2022 9:04 AM] |
0.5590 | 0.05 (8.86%) |
0.53 | 0.02 (3.21%) |
0.45 - 3.13 | 110,397 | 210,000 | 414 | |